Clinilabs

Clinilabs Announces Leadership Expansion and Welcomes Laura Shannon as Chief Executive Officer and Promotion of Founder Gary Zammit, Ph.D., to Executive Chairperson

EATONTOWN, NJ; Aug. 13, 2026 – (Business Wire) –  Clinilabs, a leading specialty contract research organization (CRO) focused on central nervous system (CNS) drug and device development, today announced leadership expansion. Laura Shannon joins the organization as Chief Executive Officer as Gary Zammit, Ph.D., the Company’s founder, assumes the role of Executive Chairperson. This expansion…

Clinilabs Expands Executive Leadership Team With Key Appointments

4 June, 2025 – NEW YORK, NY – Clinilabs, LLC, a leading full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and medical technology development, today announced the appointments of David Hagerman as Chief Financial Officer (CFO) and Jeanine Falinski as Senior Vice President of Commercial Development. These strategic additions to the…